STE

STERIS plc

HealthcareMedical DevicesNASDAQ

$212.73

-$6.72 (-3.16%)today

Conviction

7/ 10

Fair Value$279.29

Upside+31.29%

Signal21.9

Market Cap$21.4B

52W Range$204.90–$269.44

Next EarningsMay 13

Conviction History

Conviction Changes

Mar 18, 2026, 5:04 PM6→7conviction-rescore

Premium Content

Upgrade to premium to see the full reasoning behind each conviction change.

Price History

FAIR VALUE ANALYSISMonte Carlo · 5,000 runs · 99% valid

Fair Value$88.50

Current Price$220.03

Upside / Down-59.8%

P(Undervalued)0.0%

P(20%+ Up)0.0%

P(15%+ Down)100.0%

Fair Value Distribution — percentile bands

0.0% of simulations place fair value above current price

WHAT IS PRICED IN

Revenue-Based Reverse DCF

25.8%/yr

±6.5% · revenue growth to justify current price

FCF-Based Reverse DCF

19.8%/yr

±3.1% · FCF growth to justify current price

THE GAP

Market pricing margin expansion or capex normalization

Premium Content

Upgrade to premium for full distribution data, sensitivity analysis, and segment breakdowns.

Bull Case

Steris medical device sterilization; hospital procedure volumes recovering; installed base services.

Bear Case

Hospital capex budget pressure; regulatory approval delays for new facilities.

Updated Apr 7

Research Feed

sec_10qMar 3

Conviction: unchanged

STE Q3 FY2026 (9M ended Dec 31, 2025): Solid growth amid margin headwinds; restructuring on track

STE: Broad-based 9% revenue growth (all segments positive) but Q3 gross margin down 70 bps due to tariffs/inflation despite pricing wins. AST performing best (45% margins); Healthcare/Life Sciences fa...